Ford Upgraded by Benchmark to Buy on New Management

Eufemia Didonato

Ford’s  (F) – Get Report new management and better than expected third-quarter earnings will provide a near-term catalyst for the auto-making giant, according to a Benchmark analyst, who upgraded the company to buy from hold. Analyst Michael Ward also introduced a price target of $10 a share, which is 38% above Friday’s […]

Ford’s  (F) – Get Report new management and better than expected third-quarter earnings will provide a near-term catalyst for the auto-making giant, according to a Benchmark analyst, who upgraded the company to buy from hold.

Analyst Michael Ward also introduced a price target of $10 a share, which is 38% above Friday’s closing price of $7.25.

Shares of the Dearborn, Mich., company were up nearly 1% to $7.32 in premarket trading.

“Better-than-expected North American production, a positive shift in mix, and improving metrics in the auto-credit markets … are the primary drivers for better- than-expected earnings performance in the third quarter,” Ward said in a note to investors.

In addition, Ward said, “demand in China has been better than expected and expansion of the Lincoln brand should be a plus for Ford.”

In 2019, Ford produced 700,000 F-150 trucks in North America and another 350,000 Super Duty pickups, which Ward estimated accounted for about $40 billion of annual revenue.

“The conversion of two plants (Michigan and Hermosillo) from car production to trucks by the end of 2021, by our estimates, will lead to additional increases in truck mix,” he said.

Source Article

Next Post

Avadyne Health Receives AAHAM Patient Financial Advocate Seal For Patient Excellence in Financial Communication

MOLINE, Ill., Oct. 12, 2020 /PRNewswire/ — Avadyne Health, the patient liability resolution expert, is pleased to announce it has taken the Patient Financial Advocate Pledge and been awarded the Seal indicating patient excellence in financial communication by the American Association of Healthcare Administrative Management (AAHAM) and the National Patient Financial […]